Thursday, November 14, 2019

USFDA routine cGMP inspection completed at Cipla's Patalganga facility

The inspection ended with 4 observations, none of which were repeat or related to data integrity.

from India Infoline News Service https://ift.tt/32Q2s0i
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)